{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:41:52Z","timestamp":1791607312725,"version":"4.3.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.567715","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T04:14:04Z","timestamp":1602735244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Omid","family":"Rezahosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Leth","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Dehlb\u00e6k","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Schwartz","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Perch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21st century","volume":"6","author":"Black","year":"2018","journal-title":"Ann Transl Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/TP.0b013e3182466248","article-title":"Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis","volume":"93","author":"Ling","year":"2012","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0029-1192059","article-title":"Long-term care of the liver allograft recipient","volume":"29","author":"Mells","year":"2009","journal-title":"Semin Liver Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12879-019-4207-9","article-title":"Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial","volume":"19","author":"Drabe","year":"2019","journal-title":"BMC Infect Dis."},{"key":"B5","first-page":"s12","article-title":"An overview of immunosuppression in solid organ transplantation","volume":"21","author":"Enderby","year":"2015","journal-title":"Am J Manag Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.anclin.2017.04.001","article-title":"Overview of immunosuppressive therapy in solid organ transplantation","volume":"35","author":"Holt","year":"2017","journal-title":"Anesth Clin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/MOT.0000000000000661","article-title":"Antimicrobial stewardship in transplant patients","volume":"24","author":"Hand","year":"2019","journal-title":"Curr Opin Organ Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e13809","DOI":"10.1111\/ctr.13809","article-title":"Monitoring cell-mediated immunity during immunosuppression reduction in heart transplant recipients with severe systemic infections","volume":"34","author":"Weston","year":"2020","journal-title":"Clin Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"108312","DOI":"10.1101\/718627","article-title":"Towards standardization of immune functional assays","volume":"210","author":"Mouton","year":"2019","journal-title":"Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3389\/fimmu.2018.02367","article-title":"Immune functional assays, from custom to standardized tests for precision medicine","volume":"9","author":"Albert-Vega","year":"2018","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"45969","DOI":"10.1038\/srep45969","article-title":"Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6","volume":"7","author":"Ruhwald","year":"2017","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3947\/ic.2017.49.3.161","article-title":"Immunological prediction of cytomegalovirus (CMV) replication risk in solid organ transplantation recipients: approaches for regulating the targeted anti-CMV prevention strategies","volume":"49","author":"Han","year":"2017","journal-title":"Infect Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jim.2013.11.019","article-title":"Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients","volume":"403","author":"Martinez-Flores","year":"2014","journal-title":"J Immunol Methods."},{"key":"B15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","article-title":"ATP synthesis and storage","volume":"8","author":"Bonora","year":"2012","journal-title":"Purinergic Signal."},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.7182\/pit2014664","article-title":"Current insights: use of immuknow in heart transplant recipients","volume":"24","author":"Andrikopoulou","year":"2014","journal-title":"Prog Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.healun.2008.06.005","article-title":"Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection","volume":"27","author":"Bhorade","year":"2008","journal-title":"J Heart Lung Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"B19","year":"2017","journal-title":"QuantiFERON\u00ae-TB Gold Plus (QFT\u00ae-Plus) ELISA Package Insert"},{"key":"B20","volume-title":"The T-SPOT.TB Test Package Insert","year":"2016"},{"key":"B21","year":"2018","journal-title":"QuantiFERON\u00ae-TB Gold (QFT\u00ae) ELISA Package Insert"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1128\/JCM.02403-07","article-title":"Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis","volume":"46","author":"Chee","year":"2008","journal-title":"J Clin Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e13087","DOI":"10.1111\/tid.13087","article-title":"High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates","volume":"21","author":"Wigg","year":"2019","journal-title":"Transpl Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-\u03b3) release assays. A systematic review","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1038\/s41598-018-24285-3","article-title":"Prospective comparison of QFT-GIT and T-SPOT","volume":"8","author":"Du","year":"2018","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejim.2007.03.020","article-title":"Limitations of the QuantiFERON-TB gold test in detecting mycobacterium tuberculosis infection in immunocompromised patients","volume":"19","author":"Hornum","year":"2008","journal-title":"Eur J Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0222920","DOI":"10.1371\/journal.pone.0222920","article-title":"A novel strategy for interpreting the T-SPOT","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/ajt.12787","article-title":"Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus M. tuberculosis in samples from deceased organ donors","volume":"14","author":"Schmidt","year":"2014","journal-title":"Am J Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","article-title":"Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV","volume":"9","author":"Walker","year":"2007","journal-title":"Transpl Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12865-017-0195-y","article-title":"An optimized IFN-\u03b3 ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity","volume":"18","author":"Barabas","year":"2017","journal-title":"BMC Immunol."},{"key":"B31","volume-title":"The T-SPOT.CMV Test Package Insert","year":"2017"},{"key":"B32","first-page":"259","article-title":"Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells","volume":"13","author":"Tanguay","year":"1994","journal-title":"Lymphokine Cytokine Res."},{"key":"B33","unstructured":"2020"},{"key":"B34","unstructured":"2020"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/TP.0000000000000650","article-title":"Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial","volume":"99","author":"Ravaioli","year":"2015","journal-title":"Transplantation."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-gamma-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/TP.0000000000002454","article-title":"A randomized study of quantiferon cmv-directed vs. fixed-duration valganciclovir prophylaxis to reduce late CMV after lung transplantation","volume":"103","author":"Westall","year":"2019","journal-title":"Transplantation."},{"key":"B42","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.healun.2019.01.279","article-title":"Quantiferon-CMV guided virostatic prophylaxis after heart transplantation","volume":"38","author":"Poglajen","year":"2019","journal-title":"J Hear Lung Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant."},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz1209","article-title":"Cellular immunity to predict the risk of cytomegalovirus infection in kidney transplantation: a prospective, interventional, multicenter clinical trial","volume-title":"Clin Infect Dis","author":"Jarque","year":"2020"},{"key":"B45","volume-title":"The Role of ImmuKnow","year":"2011"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e030648","DOI":"10.1136\/bmjopen-2019-030648","article-title":"Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial","volume":"9","author":"Paez-Vega","year":"2019","journal-title":"BMJ Open."},{"key":"B47","unstructured":"Randomized Study Comparing QuantiFERON-CMV Based vs. Standard Cytomegalovirus (CMV) Surveillance Protocol in Pre-emptive Therapy for Cytomegalovirus Prevention After Renal2018"},{"key":"B48","volume-title":"Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients","year":"2016"},{"key":"B49","article-title":"Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-Specific Treatment After Induction Thymoglobulin","year":"2016"},{"key":"B50","volume-title":"Cell-mediated Immunity for Prevention of CMV Disease","year":"2015"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the swiss transplant cohort study","volume-title":"Clin Infect Dis","author":"van Delden","year":"2020"},{"key":"B52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12254-019-0507-4","article-title":"Immunosuppression after renal transplantation","volume":"12","author":"Neuwirt","year":"2019","journal-title":"Memo Mag Eur Med Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e13189","DOI":"10.1111\/tid.13189","article-title":"The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients","volume":"21","author":"Gardiner","year":"2019","journal-title":"Transpl Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.trre.2007.06.002","article-title":"Quality of life after solid organ transplantation","volume":"21","author":"Ortega","year":"2007","journal-title":"Transplant Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/lt.23497","article-title":"ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis","volume":"18","author":"Rodrigo","year":"2012","journal-title":"Liver Transplant."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1016\/j.transproceed.2014.09.109","article-title":"Performance of the immuknow assay in differentiating infection and acute rejection after kidney transplantation: a meta-analysis","volume":"46","author":"Wang","year":"2014","journal-title":"Transplant Proc."},{"key":"B57","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transplant."},{"key":"B58","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation."},{"key":"B59","article-title":"Interferon-gamma release assay for cytomegalovirus (IGRA-CMV) for risk stratification of posttransplant cmv infection: is it time to apply IGRA-CMV in routine clinical practice?","volume-title":"Clin Infect Dis","author":"Kim","year":"2020"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e13513","DOI":"10.1111\/ctr.13513","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567715\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T04:14:16Z","timestamp":1602735256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567715\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2020.567715"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.567715","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"article-number":"567715"}}